4//SEC Filing
Currie Mark G 4
Accession 0001209191-23-039132
CIK 0001446847other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:26 PM ET
Size
4.9 KB
Accession
0001209191-23-039132
Insider Transaction Report
Form 4
Currie Mark G
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2023-06-20+22,350→ 544,108 total
Footnotes (1)
- [F1]The restricted stock, granted pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001478244
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 5:26 PM ET
- Size
- 4.9 KB